Imperial College London

Professor Anthony Gordon

Faculty of MedicineDepartment of Surgery & Cancer

Chair in Anaesthesia and Critical Care
 
 
 
//

Contact

 

anthony.gordon

 
 
//

Location

 

ICUQueen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Thomas:2020:10.1177/1751143720938894,
author = {Thomas, K and Patel, A and Sadique, MZ and Grieve, RD and Mason, AJ and Moler, S and Gordon, AC and Rowan, KM and Mouncey, PR and Lamontagne, F and Harrison, DA},
doi = {10.1177/1751143720938894},
journal = {J Intensive Care Soc},
pages = {230--231},
title = {Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in article.},
url = {http://dx.doi.org/10.1177/1751143720938894},
volume = {21},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - The 65 trial is a pragmatic, multicentre, parallel-group, open-label, randomised clinical trial of permissive hypotension (targeting a mean arterial pressure target of 60-65 mmHg during vasopressor therapy) versus usual care in critically ill patients aged 65 years or over with vasodilatory hypotension. The trial will recruit 2600 patients from 65 United Kingdom adult general critical care units. The primary outcome is all-cause mortality at 90 days. An economic evaluation is embedded. This paper describes the proposed statistical and health economic analysis for the 65 trial.
AU - Thomas,K
AU - Patel,A
AU - Sadique,MZ
AU - Grieve,RD
AU - Mason,AJ
AU - Moler,S
AU - Gordon,AC
AU - Rowan,KM
AU - Mouncey,PR
AU - Lamontagne,F
AU - Harrison,DA
DO - 10.1177/1751143720938894
EP - 231
PY - 2020///
SN - 1751-1437
SP - 230
TI - Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in article.
T2 - J Intensive Care Soc
UR - http://dx.doi.org/10.1177/1751143720938894
UR - https://www.ncbi.nlm.nih.gov/pubmed/32782462
VL - 21
ER -